Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Prescription medicine · generic available

Miconazole nitrate, zinc oxide, white petrolatum

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Miconazole nitrate, zinc oxide, white petrolatum key facts

Used for
• VUSION Ointment is indicated for adjunctive treatment of diaper dermatitis when complicated by documented candidiasis (microscopic evidence of pseudohyphae and /or budding yeast) in immunocompetent pediatric patients 4 weeks and older. (source)
Prescription or over the counter
Prescription (Rx)
Generic available
Yes
Typical pharmacy cost
$9.12 per gram (miconazole nitrate 0.25% · petrolatum 81.35% · zinc oxide 15%; NADAC)
Latest FDA recall
None listed

Sources: FDA label (August 15, 2018); FDA NDC Directory (November 13, 2026); CMS NADAC (November 11, 2026); FDA enforcement reports (November 10, 2026). Not medical advice.

Quick answers

What is Miconazole nitrate, zinc oxide, white petrolatum used for?
The FDA-approved label (Vusion, Mylan Pharmaceuticals Inc., August 15, 2018) says: “• VUSION Ointment is indicated for adjunctive treatment of diaper dermatitis when complicated by documented candidiasis (microscopic evidence of pseudohyphae and /or budding yeast) in immunocompetent pediatric patients 4 weeks and older. • VUSION Ointment should not be used as a substitute for frequent diaper changes. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
What are the side effects of Miconazole nitrate, zinc oxide, white petrolatum?
The “Adverse Reactions” section of the FDA label (Vusion, Mylan Pharmaceuticals Inc., August 15, 2018) begins: “To report SUSPECTED ADVERSE REACTIONS, contact Mylan at 1-877-446-3679 (1-877-4-INFO-RX) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rate observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.” … This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
What are the drug interactions of Miconazole nitrate, zinc oxide, white petrolatum?
The “Drug Interactions” section of the FDA label (Vusion, Mylan Pharmaceuticals Inc., August 15, 2018) begins: “Drug-drug interaction studies were not conducted. Women who take a warfarin anticoagulant and use a miconazole intravaginal cream or suppository may be at risk for developing an increased prothrombin time, international normalized ratio (INR), and bleeding. The potential for this interaction between warfarin and VUSION is unknown.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Miconazole nitrate, zinc oxide, white petrolatum have a boxed warning?
No. None of the 2 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Miconazole nitrate, zinc oxide, white petrolatum?
No current shortage is listed by the FDA for the products of this medicine (FDA data from November 13, 2026).
Has Miconazole nitrate, zinc oxide, white petrolatum been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Miconazole nitrate, zinc oxide, white petrolatum?
1 company lists prescription products of Miconazole nitrate, zinc oxide, white petrolatum in the FDA NDC Directory, including Mylan Pharmaceuticals Inc.

What Miconazole nitrate, zinc oxide, white petrolatum is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

• VUSION Ointment is indicated for adjunctive treatment of diaper dermatitis when complicated by documented candidiasis (microscopic evidence of pseudohyphae and /or budding yeast) in immunocompetent pediatric patients 4 weeks and older. • VUSION Ointment should not be used as a substitute for frequent diaper changes. …

— FDA label: Vusion, Mylan Pharmaceuticals Inc., effective August 15, 2018. Read the full label on DailyMed →

Label quoted: the one for the most common form (ointment, topical), Vusion, Mylan Pharmaceuticals Inc.; it covers 1 product in the FDA NDC Directory. The side effects, interactions, dosage and pregnancy quotes below come from this same label.

The FDA has 2 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

0 of 2 FDA labels for this medicine have a boxed warning.

Miconazole nitrate, zinc oxide, white petrolatum side effects

Quoted from the “Adverse Reactions” section of the FDA-approved label. Tell your doctor about any side effect that worries you.

To report SUSPECTED ADVERSE REACTIONS, contact Mylan at 1-877-446-3679 (1-877-4-INFO-RX) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rate observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.

Read more of this section

A total of 835 infants and young children were evaluated in the clinical development program. Of 418 subjects in the VUSION group, 58 (14%) reported one or more adverse events. Of 417 subjects in the zinc oxide/white petrolatum control group, 85 (20%) reported one or more adverse events. Adverse events that occurred at a rate of ≥ 1% for subjects who were treated with VUSION were approximately the same in type and frequency as for subjects who were treated with zinc oxide/white petrolatum ointment. 6.2 Post-marketing Experience The following adverse reactions have been identified during post approval use of VUSION. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Gastrointestinal Disorders: vomiting General Disorders and Administration Site Conditions: burning sensation, condition aggravated, inflammation, pain Injury, Poisoning and Procedural Complications: accidental exposure Skin and Subcutaneous Tissue Disorders: blister, dermatitis contact, diaper dermatitis, dry skin, erythema, pruritus, rash, skin exfoliation

— FDA label: Vusion, Mylan Pharmaceuticals Inc., effective August 15, 2018. Read the full label on DailyMed →

Miconazole nitrate, zinc oxide, white petrolatum drug interactions

Quoted from the “Drug Interactions” section of the FDA-approved label. Tell your pharmacist about every medicine, vitamin and herbal product you take.

Drug-drug interaction studies were not conducted. Women who take a warfarin anticoagulant and use a miconazole intravaginal cream or suppository may be at risk for developing an increased prothrombin time, international normalized ratio (INR), and bleeding. The potential for this interaction between warfarin and VUSION is unknown.

— FDA label: Vusion, Mylan Pharmaceuticals Inc., effective August 15, 2018. Read the full label on DailyMed →

Miconazole nitrate, zinc oxide, white petrolatum dosage

Quoted from the “Dosage and Administration” section of the FDA-approved label. Your own dose is the one your doctor prescribes: do not change it on your own.

VUSION is not for oral, ophthalmic, or intravaginal use. Before applying VUSION, gently cleanse the skin with lukewarm water and pat dry with a soft towel. Avoid using any scented soaps, shampoos, or lotions on the diaper area. Gently apply a thin layer of VUSION to the diaper area with each diaper change for 7 days. Do not rub VUSION into the skin as this may cause additional irritation. Thoroughly wash hands after applying VUSION.

Read more of this section

Continue treatment for the full 7 days, even if there is improvement. Do not use VUSION for longer than 7 days. The safety of VUSION when used for longer than 7 days is not known. If symptoms have not improved by day 7, see your health care provider.

  • VUSION Ointment is for topical use only. VUSION Ointment is not for oral, ophthalmic, or intravaginal use. (2)
  • VUSION Ointment should be applied as a thin layer to the affected area at each diaper change for 7 days. (2)
  • VUSION Ointment should be used as part of a treatment regimen that includes gentle cleansing of the diaper area and frequent diaper changes. (2)

— FDA label: Vusion, Mylan Pharmaceuticals Inc., effective August 15, 2018. Read the full label on DailyMed →

Miconazole nitrate, zinc oxide, white petrolatum in pregnancy

Quoted from the pregnancy part of the FDA-approved label. Ask your doctor before you take any medicine while pregnant or planning a pregnancy.

Risk Summary There are no available data on VUSION Ointment use in pregnant women to inform a drug‑associated risk for adverse developmental outcomes. In animal reproduction studies, prolonged gestation, increased number of resorptions, and decreased numbers of live young were observed after oral administration of miconazole nitrate during organogenesis to pregnant rats and rabbits.

Read more of this section

No comparisons of animal exposure with human exposure may be calculated due to minimal systemic exposure in humans after topical administration of VUSION [see Clinical Pharmacology (12.3)]. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. Data Animal Data Miconazole nitrate administration has been shown to result in prolonged gestation and decreased numbers of live young in rats and in increased number of resorptions and decreased number of live young in rabbits at oral doses of 100 mg/kg/day and 80 mg/kg/day.

— FDA label: Vusion, Mylan Pharmaceuticals Inc., effective August 15, 2018. Read the full label on DailyMed →

Forms and how it is given

Dosage formsOintment
RouteTopical
Prescription products2 in the FDA NDC Directory
Brand namesVusion

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Miconazole nitrate, zinc oxide, white petrolatum, by strength and form
Strength and formGeneric or brandPharmacies pay
miconazole nitrate 0.25% · petrolatum 81.35% · zinc oxide 15%
ointment
Generic $9.12 per gram

NADAC list of November 11, 2026; these prices took effect on January 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
NDA021026
VUSION
MylanFebruary 16, 2006 5, latest August 29, 2018
2018: Labeling · 2016: Manufacturing (CMC) · 2014: Manufacturing (CMC)

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)831391, 831393
SPL set ID of the quoted labelb44b452d-3630-4cb5-8ed1-1f8edac4690c
FDA labels (SPL)2
FDA applicationsNDA021026
Active ingredients (FDA)MICONAZOLE / PETROLATUM / ZINC OXIDE

Next steps

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — Vusion, Mylan Pharmaceuticals Inc., effective August 15, 2018; via openFDA, FDA data exported November 13, 2026, retrieved November 14, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers